SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000921895-24-001086
Filing Date
2024-05-08
Accepted
2024-05-08 16:53:29
Documents
4

Document Format Files

Seq Description Document Type Size
1 dfan14a11882nvax_05082024.htm DFAN14A 26470
2 GRAPHIC image_001.jpg GRAPHIC 19705
3 GRAPHIC image_002.jpg GRAPHIC 7800
4 GRAPHIC image_003.jpg GRAPHIC 9633
  Complete submission text file 0000921895-24-001086.txt   79603
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Subject) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-26770 | Film No.: 24927120
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 2301 SUGAR BUSH RD SUITE 510 RALEIGH NC 27612
Business Address 2301 SUGAR BUSH RD SUITE 510 RALEIGH NC 27612 919 719 6360
SHAH CAPITAL MANAGEMENT (Filed by) CIK: 0001383838 (see all company filings)

IRS No.: 201804775 | State of Incorp.: NC | Fiscal Year End: 1231
Type: DFAN14A